Dementia as a manifestation of degenerative diseases of nervous system: controversial questions of pathogenesis, prospects of treatment and prevention
https://doi.org/10.26295/0S.2019.23.44.008
Abstract
The article covers dementia in elderly patients and Alzheimer’s disease as the most frequent reason of dementia. Clinical manifestations and diagnostic criteria for Alzheimer’s disease were considered, as well as approaches to its treatment.
About the Authors
N. S. Makarov
ФГБОУ ВО СГМУ им. В. И. Разумовского МЗ РФ
Россия
Россия
T. O. Kolokolova
ФГБОУ ВО МГППУ
Россия
Россия
O. V. Kolokolov
ФГБОУ ВО СГМУ им. В. И. Разумовского МЗ РФ
Россия
Россия
V. V. Yudina
ФГБОУ ВО СГМУ им. В. И. Разумовского МЗ РФ
Россия
Россия
E. V. Lukina
ФГБОУ ВО СГМУ им. В. И. Разумовского МЗ РФ
Россия
Россия
References
1. Левин О. С. Алгоритмы диагностики и лечения деменции. М.: МЕДпресс-информ, 2011. 192 с.
2. Всемирная Организация Здравоохранения. Деменция [Электронный ресурс]. - Режим доступа: https://www.who.int/ru/news-room/fact-sheets/detail/dementia - Заглавие с экрана. - (Дата обращения: 21.09.2019).
3. World Health Organization. Priority diseases and reasons for inclusion. Alzheimer Disease and other Dementias [Электронный ресурс]. - Режим доступа: https://www.who.int/medicines/areas/priority_medicines/Ch6_11Alzheimer.pdf - Заглавие с экрана. - (Дата обращения: 21.09.2019).
4. McKhanna M., Knopmanc D. S., Chertkow H. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Guy // Alzheimers Dement. 2011. Vol. 7: p. 263-269.
5. Sperling R. A., Aisen P. S., Beckett L. A. et al. Association workgroups on diagnostic guidelines for Alzheimer’s disease Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease // Alzheimers Dement. 2011. Vol. 7: p. 280-292.
6. Nir Lipsman N., Meng Y., Bethune A. J. et al. Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound // Nat Commun. 2018. Vol. 9. P. 2336.
7. Iliff J. J., Nedergaard M. Is there a cerebral lymphatic system? // Stroke. 2013. Vol. 44. P. 3-5.
8. Jessen N. A., Finmann Munk A. S., Lundgaard I. et al. The Glymphatic System - A Beginner’s GuideNeurochem // Neurochemical Research. 2015. Vol. 40. P. 2583-2599.
9. Da Mesquita S., Louveau A., Vaccari A. et al. Functional aspects of meningeal lymphatics in aging and Alzheimer’s disease // Nature. 2018. Vol. 560 (7717). P. 185-191.
10. Pu-Ting Xu, Yi-Ju Li, Xue-Jun Qin et al. A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease // Mol Cell Neurosci. 2007. Vol. 36. P. 313-331.
11. U. S. National Library of Medicine. ClinicalTrials.gov [Электронный ресурс]. - Режим доступа: https://clinicaltrials.gov/ct2/results?cond=Alzheimer+Disease - Заглавие с экрана. - (Дата обращения: 21.09.2019).
12. Cummingsa J., Leea G., Rittera A. et al. Alzheimer’s disease drug development pipeline: 2018 // Alzheimers Dement (N Y). 2018. Vol. 4. P. 195-214.
13. Lee H. E., Lim D., Lee J. Y. et al. Recent tau-targeted clinical strategies for the treatment of Alzheimer’s disease // Newlands Press Future Med. Chem. 2019. Vol. 11 (15). P.1845-1848.
14. Moran M., Lynch C. A., Walsh C. et al. Sleep disturbance in mild to moderate Alzheimer’s disease // Sleep Med. 2005. Vol. 6 (4). P. 347-352.
15. Guarnieri B., Cerroni G., Sorbi S. Sleep disturbances and cognitive decline: recommendations on clinical assessment and the management // Arch Ital Biol. 2015. Vol. 153 (2-3). P. 225-230.
16. Kang J. E., Lim M. M., Bateman R. J. et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle // Science. 2009. Vol. 326 (5955). P. 1005-1007.
17. Xie L., Kang H., Xu Q. et al. Sleep drives metabolite clearance from the adult brain // Science 2013. Vol. 342 (6156). P. 373-377.
18. Ju Y.-E.S., Brendan P. P., Lucey B. P. et al. Sleep and Alzheimer disease pathology - a bidirectional relationship // Nat Rev Neurol. 2014. Vol. 10 (2). P. 115-119.
19. Noel-Storr A., McShane R. ALOIS - the next phase: a comprehensive study-based register of diagnostic studies (www.medicine.ox.ac.uk/alois) // Alzheimers Dement. 2011. Vol. 7 (4). P. 324-325-665.
20. Mancioppi G., Fiorini L., Timpano M. et al. Novel Technological Solutions for Assessment, Treatment, and Assistance in Mild Cognitive Impairment // Front Neuroinform. 2019. Vol. 13. P. 58.
21. BenthamC., De Marco M., Vennericorresponding A. The Modulatory Effect of Cerebrovascular Burden in Response to Cognitive Stimulation in Healthy Ageing and Mild Cognitive Impairment // Neural Plast. 2019. 2019. ID2305318, 12 P.
22. Chen J., DuanY., Li H. Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis // Clin Interv Aging. 2019. Vol. 14. P. 1243-1254.
23. Cognitive Stimulation Therapy [Электронный ресурс]. - Режим доступа: http://www.cstdementia.com - Заглавие с экрана. - (Дата обращения: 21.09.2019).
24. The National Institute for Health and Care Excellence. Guidance [Электронный ресурс]. - Режим доступа: https://www.nice.org.uk/guidance - Заглавие с экрана. - (Дата обращения: 21.09.2019).
25. Spector A., Orrell M. Davies S. Woods B. Reality orientation for dementia // Cochrane Database Syst Rev. 2000; (4): CD001119.
26. Tiberio L., Cesta A., Cortellessa G. et al. Assessing affective response of older users to a telepresence robot using a combination of psychophysiological measures // In 2012 IEEE RO-MAN: The 21st IEEE International Symposium on Robot and Human Interactive Communication. 2012. P. 833-838.
27. Ainasoja A., Pertuz S., K?m?r?inen J. Smartphone Teleoperation for Self-balancing Telepresence Robots // In Proceedings of the 14th International Joint Conference on Computer Vision, Imaging and Computer Graphics Theory and Applications. 2019. Vol. 4. P. 561-568.
28. Нейропсихологические тесты и программы стимуляции когнитивных функций [Электронный ресурс]. - Режим доступа: https://www.cognifit.com/ru/whats-cognifit - Заглавие с экрана. - (Дата обращения: 21.09.2019).
29. Kivipelto M., Solomon A., Ahtiluoto S. et al. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. // Alzheimers Dement. 2013. Vol. 9 (6). P. 657-665.
30. Sindi S., Ngandu T., Hovatta I. Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial // J Alzheimers Dis. 2017. Vol. 59 (4). P. 1459-1470.
31. Медвестник. Портал российского врача. Реальное число больных с деменцией резко расходится с данными Минздрава [Электронный ресурс]. - Режим доступа: https://medvestnik.ru/content/news/Realnoe-chislo-bolnyh-s-demenciei-rezko-rashoditsya-s-dannymi-Minzdrava.html - Заглавие с экрана. - (Дата обращения: 21.09.2019).
32. Lucey B. P., Bateman R. J. Amyloid-? diurnal pattern: possible role of sleep in Alzheimer’s disease pathogenesis // Neurobiol. Aging. 2014. Vol. 35. P. 29-34.
33. Morris J. C., Roe C. M., Grant E. A. et al. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease // Arch. Neurol.2009. Vol. 66 (12). P. 1469-1475.
34. Alzheimer’s Association. 2019 Alzheimer’s Disease Facts and Figures // Alzheimers Dement. 2019. Vol. 15 (3). P. 321-387.
Review
For citations:
Makarov N.S., Kolokolova T.O., Kolokolov O.V., Yudina V.V., Lukina E.V. Dementia as a manifestation of degenerative diseases of nervous system: controversial questions of pathogenesis, prospects of treatment and prevention. Lechaschi Vrach. 2019;(10):40-46. (In Russ.) https://doi.org/10.26295/0S.2019.23.44.008
Views:
179
JATS XML
Email this article 
